Literature DB >> 16742479

Studies on the formation of the prothrombin-converting complex.

F Jobin1, M P Esnouf.   

Abstract

1. It has been shown that factor V accelerates the rate of conversion of prothrombin into thrombin by activated factor X, and that this activity does not depend on the presence of phospholipid. 2. Although the mechanism by which factor V increases the rate of reaction is not clear, it seems unlikely that it is converted into an enzyme. 3. The rate of conversion of prothrombin by purified activated factor X and factor V was increased threefold in the presence of phospholipid, and it is suggested that the lipid acts by adsorbing the proteins on its surface and hence increasing the local concentration of the reactants.

Entities:  

Year:  1967        PMID: 16742479      PMCID: PMC1270313          DOI: 10.1042/bj1020666

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  THROMBIN AND THE INTERACTION OF FACTORS 8 AND 9.

Authors:  R BIGGS; R G MACFARLANE; K W DENSON; B J ASH
Journal:  Br J Haematol       Date:  1965-05       Impact factor: 6.998

2.  An apparatus for microelectrophoresis of small particles.

Authors:  A D BANGHAM; D H HEARD; R FLEMANS; G V SEAMAN
Journal:  Nature       Date:  1958-09-06       Impact factor: 49.962

3.  A column chromatographic separation of classes of phospholipides.

Authors:  D J HANAHAN; J C DITTMER; E WARASHINA
Journal:  J Biol Chem       Date:  1957-10       Impact factor: 5.157

4.  Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma proaccelerin.

Authors:  P HJORT; S I RAPAPORT; P A OWREN
Journal:  Blood       Date:  1955-11       Impact factor: 22.113

5.  The mechanism of action of human accelerator globulin and its relation to other clotting factors.

Authors:  M L LEWIS; A G WARE
Journal:  Blood       Date:  1954-05       Impact factor: 22.113

6.  Efficiency of oxidative phosphorylation during the oxidation of pyruvate.

Authors:  W BARTLEY
Journal:  Biochem J       Date:  1953-07       Impact factor: 3.857

7.  The isolation of factor V from bovine plasma.

Authors:  M P Esnouf; F Jobin
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

8.  Purification of a bovine plasma protein (factor VII) which is required for the activity of lung microsomes in blood coagulation.

Authors:  W J Williams; D G Norris
Journal:  J Biol Chem       Date:  1966-04-25       Impact factor: 5.157

9.  Coagulant activity of tiger snake (Notechis scutatus scutatus) venom.

Authors:  F Jobin; M P Esnouf
Journal:  Nature       Date:  1966-08-20       Impact factor: 49.962

10.  PHOSPHATIDIC ACID SYNTHESIS IN YEAST.

Authors:  N J KUHN; F LYNEN
Journal:  Biochem J       Date:  1965-01       Impact factor: 3.857

View more
  17 in total

1.  Paratopic interaction, a mechanism in the generation of structure bound enzymatic activity.

Authors:  H C Hemker; H L Frank
Journal:  Experientia       Date:  1977-07-15

2.  Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.

Authors:  C Y Liu; C F Scott; A Bagdasarian; J V Pierce; A P Kaplan; R W Colman
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  The purification and properties of factor X from pig serum and its role in hypercoagulability in vivo.

Authors:  R J Dupe; R M Howell
Journal:  Biochem J       Date:  1973-06       Impact factor: 3.857

4.  A method for the simultaneous isolation of factor X and prothrombin from bovine plasma.

Authors:  M P Esnouf; P H Lloyd; J Jesty
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

5.  Enzymology and blood coagulation.

Authors:  M P Esnouf
Journal:  Biochem J       Date:  1969-11       Impact factor: 3.857

6.  Mathematical model of the activation of prothrombin by factor Xa and factory Vt.

Authors:  W Liniger; G Karreman; R Rawala; R Colman
Journal:  Bull Math Biol       Date:  1980       Impact factor: 1.758

7.  Factor V anticoagulants: clinical, biochemical, and immunological observations.

Authors:  D I Feinstein; S I Rapaport; W G McGehee; M J Patch
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

8.  A polypeptide region of bovine prothrombin specific for binding to phospholipids.

Authors:  S N Gitel; W G Owen; C T Esmon; C M Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

9.  The preparation of activated factor X and its action on prothrombin.

Authors:  J Jesty; M P Esnouf
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

10.  Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes.

Authors:  Krishna Kumar Turaga; P Chakradhara Rao; G Sripad
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.